Medicon Valley Academy and Norgenta North German Life Science Agency agree on cooperation in two projects
On the occasion of a delegation of the First Mayor of the Free and Hanseatic City Hamburg, Ole von Beust to the Øresund region, an agreement between Norgenta North German Life Science Agency and the Medicon Valley Academy was signed in Lund/Sweden. Subject of the agreement are two strategic projects in which the regions, represented by the agencies, will cooperate in future. The first project "The European Drug Discovery LinkUp" was initiated by the Hamburg biotechnology company Evotec AG together with Norgenta.
The aim of the project is to facilitate academic institutions to work on therapeutic molecules according to industrial standards and on industrial scale. The Medicon Valley Academy will support the project partners in winning academic institutions from the Øresund region for this European project. "With this agreement we will pave the way for integrating the expertise of the Øresund region's first-class research facilities into the LinkUp project" stresses Dr. Kathrin Adlkofer, Norgenta's managing director, subsequent to signing the agreement. Prof. Per Belfrage, Chairman of the Medicon Valley Academy Board, appreciates the cooperation. "The cooperation with Norgenta will, due to this agreement, be started with two already concrete projects being very important for both regions."
The second project is the application of the Øresund region as hosting region of the Innovative Medicine Initiative (IMI) secretariat, an initiative presented by the European Union together with the EFPIA (European Federation of Pharmaceutical Industry and Associations). IMI is a European technology platform aiming not only at the faster development of safe and effective drugs. It also aims at the revitalisation of the European Scientific Community in the field of Biomedicals.
Medicon Valley Academy and Norgenta have, due to their commitment in the meta network ScanBalt, a considerable interest to settle this secretariat within the ScanBalt region. In future, both regions will exchange information concerning important projects and aim at cooperating beyond these first two concrete projects.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
ThromboGenics Announces License Agreement with Bharat Biotech for Novel Thrombolytic Agent
Diamond ring architecture of a protein complex
Taurine deficiency in sperm causes male infertility
Researchers from BGU have generated a promising drug candidate for the treatment of Psoriasis
Novartis begins shipment of Fluvirin seasonal influenza vaccine for the U.S. market ahead of schedule - Providing 30 million doses of Fluvirin vaccine in the U.S., to support the annual seasonal influenza vaccination campaign
Giant Viruses Infect Deadly Parasite - New unusual giant virus discovered in wastewater treatment plant
Active wound healing can accelerate tumour formation
SUANFARMA announces a collaboration with Reyoung Pharmaceutical - The main objective of the collaboration is to introduce generic pharmaceutical ingredients to the market for the treatment of infectious diseases
